Xcel Labs

Pharmaceutical formulations marketing and health care products in India.

About Xcel Labs

Xcel Labs is a Healthcare company. Pharmaceutical formulations marketing and health care products in India. Its Indian entity X-Cel Labs Private Limited reported revenue of β‚Ή1.55 Cr. Xcel Labs offers products and services including Gynecological Products and Pediatric Products. Its focus areas include Pharmaceuticals, Formulations Marketing, Drug Manufacturing and Medical Supplies.

Company details

Xcel Labs is identified as a pharmaceutical formulations marketing company that was established in 2008 to deliver innovative healthcare products addressing unmet needs. Products are provided in segments like ENT, GYNAC, PEDIATRIC, and CONSULTANT PHYSICIAN, covering treatments for vertigo, tinnitus, anti-allergic solutions, and care for pre and post-natal needs. A national presence is sought, with ethical recognition by medical practitioners being emphasized. Core values such as customer centricity, synergy among departments, discipline in operations, and a pursuit of excellence are maintained. Offices are situated in Mumbai and Vadodara, India, where products are supplied to physicians.

  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website xcellabs.in
  • Legal Name Xcel Labs Pvt. Ltd
  • Date of Incorporation 05 Oct, 2004
  • Jurisdiction Vadodara, Gujarat, India
Key Metrics
  • Indian entity revenue
    ₹1.55 Cr

    FY 2025 · -7% YoY

  • Indian entity net profit
    ₹1.1 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹4.4 Lakh

    FY 2025 · 3% margin

Products & Services of Xcel Labs

Xcel Labs offers a comprehensive portfolio of products and services, including Gynecological Products and Pediatric Products.

Gynecological Products
Pharmaceutical Products

Products for pre and post-natal care are provided in the GYNAC category.

Pediatric Products
Pharmaceutical Products

Nasal and ear drops are offered in the PEDIATRIC category for niche segments.

Board of directors of X-Cel Labs Private Limited (Xcel Labs)

X-Cel Labs Private Limited is the primary company behind Xcel Labs. The board of X-Cel Labs Private Limited currently have 2 directors; the longest-serving is Amruta Sanjay Kelkar, appointed in 2004. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Amruta Sanjay Kelkar
DIN 02052943
Director05 Oct 200422 yrs 1 moX-Cel Labs Private Limited
Sanjay Sudhakar Kelkar
DIN 02456358
Director01 Jan 200917 yrs 10 moX-Cel Labs Private Limited

Financials of Xcel Labs

Figures of X-Cel Labs Private Limited, the primary company behind Xcel Labs, for FY 2025. Revenue was ₹1.55 Cr (-7% year on year). Net profit was ₹1.1 Lakh (1% margin). EBITDA was ₹4.4 Lakh (3% margin). Revenue has grown at a compounded annual rate of +7% over three years and +7% over five years.

  • ₹1.55 CrRevenue · FY 2025 · -7% YoY
  • ₹1.1 LakhNet profit · 1% margin
  • ₹4.4 LakhEBITDA · 3% margin
  • ₹4 LakhPaid-up capital
  • +7%Revenue CAGR, 3 years
  • +7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of X-Cel Labs Private Limited are on its company page.

Premium access

Detailed financial statements for Xcel Labs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Xcel Labs

The primary company behind Xcel Labs, X-Cel Labs Private Limited, reported revenue of β‚Ή1.55 Cr for FY 2025, down 7% year on year.

Xcel Labs is identified as a pharmaceutical formulations marketing company that was established in 2008 to deliver innovative healthcare products addressing unmet needs. Products are provided in segments like ENT, GYNAC, PEDIATRIC, and CONSULTANT PHYSICIAN, covering treatments for vertigo, tinnitus, anti-allergic solutions, and care for pre and post-natal needs. A national presence is sought, with ethical recognition by medical practitioners being emphasized. Core values such as customer centricity, synergy among departments, discipline in operations, and a pursuit of excellence are maintained. Offices are situated in Mumbai and Vadodara, India, where products are supplied to physicians.

Xcel Labs offers Gynecological Products and Pediatric Products.

Xcel Labs operates through X-Cel Labs Private Limited.

The legal entities of Xcel Labs currently have 2 directors, including Amruta Sanjay Kelkar, Sanjay Sudhakar Kelkar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available